RJA
CELG

Raymond James & Associates’s Celgene Corp CELG Stock Holding History

Raymond James & Associates’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-261,289
Closed -$25.9M – 3835
2019
Q3 		$25.9M Sell
261,289
-20,438
-7% -$1.94M 0.04% 445
2019
Q2 		$26M Sell
281,727
-106,366
-27% -$10.1M 0.04% 450
2019
Q1 		$36.6M Sell
388,093
-419,320
-52% -$36.7M 0.06% 326
2018
Q4 		$51.7M Sell
807,413
-135,139
-14% -$9.98M 0.09% 207
2018
Q3 		$84.3M Buy
942,552
+125,232
+15% +$11.1M 0.13% 146
2018
Q2 		$64.9M Sell
817,320
-26,304
-3% -$2.18M 0.11% 179
2018
Q1 		$75.3M Sell
843,624
-4,106
-0.5% -$394K 0.14% 153
2017
Q4 		$88.5M Sell
847,730
-283,741
-25% -$32M 0.16% 121
2017
Q3 		$165M Buy
1,131,471
+99,232
+10% +$13.5M 0.33% 55
2017
Q2 		$134M Buy
1,032,239
+64,195
+7% +$7.87M 0.29% 64
2017
Q1 		$120M Buy
968,044
+64,145
+7% +$7.68M 0.28% 67
2016
Q4 		$105M Buy
903,899
+230,053
+34% +$25.6M 0.27% 67
2016
Q3 		$70.4M Buy
673,846
+134,671
+25% +$14.6M 0.19% 119
2016
Q2 		$53.2M Sell
539,175
-10,974
-2% -$1.14M 0.17% 130
2016
Q1 		$55.1M Buy
550,149
+44,079
+9% +$4.54M 0.19% 110
2015
Q4 		$60.6M Buy
506,070
+53,291
+12% +$6.17M 0.22% 93
2015
Q3 		$49M Buy
452,779
+33,251
+8% +$4.13M 0.2% 103
2015
Q2 		$48.6M Buy
419,528
+59,541
+17% +$6.81M 0.19% 109
2015
Q1 		$41.5M Sell
359,987
-7,775
-2% -$929K 0.18% 110
2014
Q4 		$41.1M Buy
367,762
+26,840
+8% +$2.83M 0.2% 100
2014
Q3 		$32.3M Buy
340,922
+45,483
+15% +$4.1M 0.19% 96
2014
Q2 		$25.4M Buy
295,439
+54,195
+22% +$4.12M 0.16% 123
2014
Q1 		$16.8M Sell
241,244
-17,962
-7% -$1.42M 0.12% 199
2013
Q4 		$21.9M Sell
259,206
-282
-0.1% -$22.3K 0.16% 124
2013
Q3 		$20M Buy
259,488
+12,266
+5% +$860K 0.17% 111
2013
Q2 		$14.5M Buy
+247,222
New +$14.9M 0.14% 152

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Raymond James & Associates's CELG Position: Q4 2019 in Review

Raymond James & Associates sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 261,289 shares — an estimated $25.9M sold.

Raymond James & Associates first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $165M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Raymond James & Associates reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Raymond James & Associates sold 261,289 Celgene Corp shares in Q4 2019, an estimated $25.9M.
  • Raymond James & Associates first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Raymond James & Associates's Celgene Corp position peaked at $165M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Raymond James & Associates's 13F filing for Q4 2019, filed 12 Feb 2020.